Intellectual Property

Is the National Security Exception in the TRIPS Agreement a Realistic Option in Confronting COVID-19? by Emmanuel Kolawole Oke

The Need for the Tort Law Privileges of Self-Defense and Necessity in Intellectual Property Law by Yaniv Heled, Ana Santos Rutschman & Liza Vertinsky

The Problem with Relying on Profit-Driven Models to Produce Pandemic Drugs by Yaniv Heled, Ana Santos Rutschman & Liza Vertinsky

L’executive order sulla prevenzione della censura online: quali effetti sull’autonomia dei social network? by Giuseppe Franco Ferrari

COVID-19, Patents and the Never-Ending Tension between Proprietary Rights and the Protection of Public Health

The case for compulsory licensing during COVID-19 by Hilary Wong

COVID-19 as a Trade Mark in Australia: Issues and Implications by Vicki T. Huang

Editorial: Volume 61: Intellectual Property information in the time of corona virus by Jane List in World Patent Information. 2020 Jun; 61: 101971.

COVID-19 and the Rebirth of Compulsory Licensing: An Examination of the Right to Health Care by Emaediong Akpan & Chinonyerem Ememobong

The case for compulsory licensing during COVID-19 by Hilary Wong in J. Glob. Health. 2020 Jun; 10(1): 010358

Crisis-Critical Intellectual Property: Findings from the COVID-19 Pandemic by Frank Tietze, Pratheeba Vimalnath, Leonidas Aristodemou & Jenny Molloy

Africa and counterfeit pharmaceuticals in the times of COVID-19 by Marius Schneider & Nora Ho Tu Nam in Journal of Intellectual Property Law & Practice, Volume 15, Issue 6, June 2020, Pages 417–418

Thinking Slow About IP in Times of Pandemic by González Otero, B. – IIC (2020), 51, 2020, 555–558

La scienza non sarà più la stessa. Più condivisione, cooperazione e solidarietà dopo il Covid-19? by Roberto Caso

Counterfeits, substandard goods and intellectual property crime in the COVID-19 pandemic by EUROPOL

Open COVID Pledge Seeks to Make IP Available for Use in Ending COVID-19 by Darren Franklin